Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELITE: Long-term Immunosuppression Impact on Immune Oversight in Kidney Transplant
NCT03227965Completed
- Sponsor
- CHU de Poitiers
- Start
- Jan 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Open-label trial, sponsored by CHU de Poitiers. Primary endpoint: Immune cells study at 12 months. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT03227965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227965.